## FIG: Figma, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -2.9% below STRENGTH zone (3.0-6.0%); PEG unavailable fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($33.35)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-05 | RBC Capital | $38 | $65 | -42% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-05 | RBC Capital | main | Sector Perform |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Index Venture Associ: 13.9% (+100.0%)
- Sc Us (ttgp), Ltd.: 6.1% (+100.0%)
- ICONIQ Capital, LLC: 5.1% (+100.0%)
- a16z Capital Managem: 3.9% (+100.0%)
- FMR, LLC: 1.8% (+100.0%)

### Key Risks

1. High beta (2.44) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Falling knife pattern: rapid decline without stabilization, catch risk elevated.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

Balance sheet: strong liquidity (2.9x), low leverage (D/E 0.49). Revenue growth strong at 24% YoY. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $18.4B |
| Beta | 1.00 |
| 52W Range | $32.83 - $142.92 |
| Short Interest | 7.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | N/A |
| Forward P/E | 158.9 |
| Current P/E | 101.9 |
| YoY Growth | -35.9% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from -0.6% to -2.9% (-2.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.9pp (needs >3.0% for momentum thesis). Below SMA200 (1.00x), long-term trend not supportive. RSI neutral at 43. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.88% (CS: 10) | Weak |
| RSI_14 | 42.7 | Neutral |
| MACD Histogram | 0.26 | Bullish |
| vs SMA20 | 0.981x | Below |
| vs SMA50 | 0.914x | Below |
| vs SMA200 | 1.000x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $37.05
- **Stop Loss:** $33.35 (10.0% risk)
- **Target:** $40.75 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 310
- **Position Value:** $11,485.50
- **Portfolio %:** 11.49%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-03-25 (Est: $0.06)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.05 | $0.13 | +182.3% |
| 2025Q2 | $0.08 | $0.09 | +11.0% |

---
*RULE-based L3 | 2026-01-07 09:35 | MRS_10*